Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,152,740 | 3,326,500 | 1,757,187 | 5,838,755 | 4,504,866 |
| Depreciation Amortization | 686,718 | 331,439 | 160,402 | 848,584 | 635,187 |
| Accounts receivable | N/A | N/A | N/A | -318,687 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -59,660 | N/A |
| Other Working Capital | -60,288 | -68,385 | -1,107,159 | 364,257 | -194,296 |
| Other Operating Activity | 2,350,133 | 1,472,568 | 668,342 | 339,374 | 1,255,176 |
| Operating Cash Flow | $8,129,303 | $5,062,122 | $1,478,772 | $7,012,622 | $6,200,933 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -675,728 | -429,216 | -246,216 | -1,338,307 | -1,046,427 |
| Net Acquisitions | N/A | N/A | N/A | -450 | -447 |
| Purchase Of Investment | -59,817 | -57,898 | -57,898 | -67,005 | -8,344 |
| Sale Of Investment | N/A | N/A | N/A | 22,185 | N/A |
| Purchase Sale Intangibles | -764,433 | -27,177 | -8,271 | -344,620 | -184,462 |
| Other Investing Activity | -761,607 | -25,848 | -6,942 | -341,622 | -181,482 |
| Investing Cash Flow | $-1,497,152 | $-512,962 | $-311,056 | $-1,725,199 | $-1,236,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -89,176 | -63,216 | -62,034 | -111,076 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -70,030 |
| Common Stock Repurchased | -1,757,615 | -1,212,765 | -397,313 | -2,298,567 | -1,550,196 |
| Dividend Paid | -3,158,997 | -1,853,783 | -1,853,783 | -2,909,409 | -2,891,941 |
| Other Financing Activity | 0 | 1 | 317,851 | 0 | 0 |
| Financing Cash Flow | $-5,005,788 | $-3,129,763 | $-1,995,279 | $-5,319,052 | $-4,512,167 |
| Exchange Rate Effect | -47,885 | -25,109 | -14,032 | -1,049 | 13,857 |
| Beginning Cash Position | 2,419,527 | 2,276,205 | 2,276,205 | 2,342,787 | 2,328,721 |
| End Cash Position | 3,998,005 | 3,670,493 | 1,434,610 | 2,310,109 | 2,794,644 |
| Net Cash Flow | $1,578,478 | $1,394,288 | $-841,595 | $-32,678 | $465,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,129,303 | 5,062,122 | 1,478,772 | 7,012,622 | 6,200,933 |
| Capital Expenditure | -676,199 | -429,216 | -246,216 | -1,338,907 | -1,046,725 |
| Free Cash Flow | 7,453,104 | 4,632,906 | 1,232,556 | 5,673,715 | 5,154,208 |